Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals

OBJECTIVE: Anti-HBe seroconversion and HBsAg loss are important therapeutic endpoints in patients with hepatitis B virus (HBV) infection. Quantitative measures of hepatitis B surface antigen (qHBsAg) and e antigen (qHBeAg) have been identified as potentially useful indicators of therapeutic response...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Matthews, Gail V., Ali, Rachel J., Avihingsanon, Anchalee, Amin, Janaki, Hammond, Rachel, Bowden, Scott, Lewin, Sharon R., Sasadeusz, Joe, Littlejohn, Margaret, Locarnini, Stephen L., Ruxrungtham, Kiat, Dore, Gregory J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622017/
https://ncbi.nlm.nih.gov/pubmed/23593455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061297
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky